Clinical Trials
155 trialsINFINITE
Ferring Ventures Limited
NAPOLI 3
Ipsen
KEYNOTE-966
Merck Sharp & Dohme LLC
KEYNOTE-966
Merck Sharp & Dohme LLC
innovaTV 301
Seagen Inc.
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
National Cancer Institute (NCI)
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Regeneron Pharmaceuticals
KEYNOTE-B15
Merck Sharp & Dohme LLC
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Hoffmann-La Roche
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
NovoCure Ltd.
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
SWOG Cancer Research Network
CheckMate 816
Bristol-Myers Squibb
POLARGO
Hoffmann-La Roche
IMpassion132
Hoffmann-La Roche
CheckMate 227
Bristol-Myers Squibb
PRECIOUS
Japan Breast Cancer Research Group
SQUIRE
Eli Lilly and Company
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
MAESTRO
ImmunoGenesis
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer
Pancreatic Cancer Action Network
EURTAC
Spanish Lung Cancer Group
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
National Cancer Institute (NCI)
IMvigor130
Hoffmann-La Roche
Avelumab in First-line NSCLC (JAVELIN Lung 100)
EMD Serono
RATIONALE-309
BeiGene
GECP-SCAT
Spanish Lung Cancer Group
KEYNOTE-355
Merck Sharp & Dohme LLC
GAIN
Krankenhaus Nordwest
LAPIS
Kyntra Bio
IPSOS
Hoffmann-La Roche
TROPiCS-02
Gilead Sciences
ANITA
Grupo Español de Investigación en Cáncer de Ovario
PRESERVE 2
G1 Therapeutics, Inc.
ARCTIC
AstraZeneca
GAMMA
NantCell, Inc.
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
ImmunityBio, Inc.
CONKO-007
University of Erlangen-Nürnberg Medical School
A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer
Biotech Pharmaceutical Co., Ltd.
NEOPAN
UNICANCER
CanStem111P
Sumitomo Pharma America, Inc.
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
National Cancer Institute (NCI)
Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Canadian Cancer Trials Group
Keynote-122
Merck Sharp & Dohme LLC
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
Eastern Cooperative Oncology Group
apact
Celgene
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
pharmaand GmbH
Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients
Spanish Breast Cancer Research Group
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX
SynCore Biotechnology Co., Ltd.
BIC
Corewell Health West
ATTAIN
Nektar Therapeutics